BRIEF-Ardelyx announces Tenapanor reduces pain caused by IBS-C through inhibition of TRPV-1 signaling
October 16, 2017 at 08:29 AM EDT
* Ardelyx announces Tenapanor reduces pain caused by IBS-c through inhibition of TRPV-1 signaling
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||